Bli medlem
Bli medlem

Du är här


Ad hoc: Biofrontera AG resolves on capital increase

Biofrontera AG / Keyword(s): Capital increase /Ad hoc: Biofrontera AG resolves
on capital increase . Ad hoc announcement according to § 15 WpHG. Processed
and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely
responsible for the content of this announcement.
Leverkusen, Germany, 23.04.2015 - The board of directors of Biofrontera AG
(Biofrontera) has resolved today, with the approval of the supervisory board,
to increase the registered capital of Biofrontera from currently EUR
22,196,570.00 by up to EUR 2,173,913.00 from authorized capital to up to EUR
24,370,483.00 by issuing up to 2,173,913 new no-par registered shares ("New
"). The New Shares are entitled to a participation in profits from 1 January
2014. Shareholders will be offered the statutory subscription right in such a
way that Lang&Schwarz Broker GmbH, Düsseldorf, is admitted to subscribe and
take over the New Shares at an issue price of EUR 1.00, with the obligation
to offer the New Shares to the shareholders at a ratio of 10:1 against
payment of EUR 2.30 per New Share ("Subscription Price
") for subscription ("Subscription Offer
"). The subscription period will run from 5 May 2015 to and including 19 May
2015. If not all New Shares will be placed through the Subscription Offer,
shareholders who have already exercised their subscription rights may
subscribe additional shares by way of over-subscription. Any New Shares not
acquired by subscription or over-subscription will be offered to select
investors in a private placement. The offer period for the private placement
shall end no later than three trading days after the end of the subscription
Further details will be communicated in the Subscription Offer published in
the Federal Gazette on 27 April 2015.

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611

Biofrontera AG
Tel.: +49 (0214) 87 63 2 0, Fax.: +49 (0214) 87 63 290


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biofrontera AG via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.